A possible cross-sectional association of serum total bilirubin with coronary heart disease and stroke in a Japanese health screening population
- 233 Downloads
Bilirubin is a potent antioxidant, and serum total bilirubin (TB) is reported to be negatively associated with cardiovascular disease (CVD). There has been no report on the association between TB and CVD prevalence in Japanese. The aim of the study is to examine the association between TB and CVD prevalence in a Japanese health screening population. Prevalence of CVD was studied in 3,375 Japanese men and 2,069 Japanese women. Odds ratios (ORs) of each higher quintile of TB using the lowest quintile as the reference in men and of each higher tertile of TB using the lowest tertile as the reference in women were calculated for coronary heart disease (CHD) and stroke adjusting for age, liver function tests, smoking, physical activity, and alcohol consumption. The ORs [95% confidence intervals (CIs)] for CHD and stroke of the 2nd, 3rd, 4th, and 5th quintiles of TB were 0.63 (0.37–1.07) and 0.49 (0.24–1.00), 0.45 (0.22–0.90) and 0.65 (0.28–1.51), 0.69 (0.39–1.20) and 0.37 (0.15–0.87), and 0.61 (0.34–1.09) and 0.40 (0.18–0.92), respectively in men. The ORs (95% CIs) for CHD and stroke of the 2nd and 3rd tertiles of TB were 0.63 (0.37–1.07) and 0.49 (0.24–1.00), and 0.61 (0.34–1.09) and 0.40 (0.18–0.92), respectively in women. Low TB was associated with the higher prevalence of CHD and stroke in men and with the higher prevalence of stroke in women among a Japanese health screening population.
KeywordsOxidative stress Bilirubin Coronary heart disease Stroke Risk factors
The authors thank all subjects who participated in the study, the paramedical staff at our center who assisted with the study, and Drs. Shinpei Yoshii and Masaaki Okabe at Tachikawa Medical Center and Prof. Yoshifusa Aizawa at Niigata University Graduate School of Medical and Dental Sciences for their assistance with constructing the study environment.
Conflict of interest
The authors received no grant or financial support and have no conflict of interest to disclose.
- 2.Wu TW, Fung KP, Yang CC (1994) Unconjugated bilirubin inhibits the oxidation of human low-density lipoprotein better than Trolox. Life Sci 54:477–481Google Scholar
- 4.Erdogan D, Gullu H, Yildirim E, Tok D, Kirbas I, Ciftci O, Baycan ST, Muderrisoglu H (2006) Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 184:431–437PubMedCrossRefGoogle Scholar
- 9.Troughton JA, Woodside JV, Young IS, Arveiler D, Amouyel P, Ferrières J, Ducimetière P, Patterson CC, Kee F, Yarnell JW, Evans A; PRIME Study Group (2007) Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Eur J Cardiovasc Prev Rehabil 14:79–84Google Scholar
- 12.Perlstein TS, Pande RL, Creager MA, Weuve J, Beckman JA (2008) Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999–2004. Am J Med 121:781–788.e1Google Scholar
- 19.Crisby M, Kublickiene K, Henareh L, Agewall S (2009) Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease. Heart Vessels 24:90–95PubMedCrossRefGoogle Scholar